Literature DB >> 9371603

The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: cleavage is not required for infectivity.

E C Bos1, W Luytjes, W J Spaan.   

Abstract

The spike protein (S) of the murine coronavirus mouse hepatitis virus strain A59 (MHV-A59) induces both virus-to-cell fusion during infection and syncytium formation. Thus far, only syncytium formation could be studied after transient expression of S. We have recently described a system in which viral infectivity is mimicked by using virus-like particles (VLPs) and reporter defective-interfering (DI) RNAs (E. C. W. Bos, W. Luytjes, H. Van der Meulen, H. K. Koerten, and W. J. M. Spaan, Virology 218:52-60, 1996). Production of VLPs of MHV-A59 was shown to be dependent on the expression of M and E. We now show in several ways that the infectivity of VLPs is dependent on S. Infectivity was lost when spikeless VLPs were produced. Infectivity was blocked upon treatment of the VLPs with MHV-A59-neutralizing anti-S monoclonal antibody (MAb) A2.3 but not with nonneutralizing anti-S MAb A1.4. When the target cells were incubated with antireceptor MAb CC1, which blocks MHV-A59 infection, VLPs did not infect the target cells. Thus, S-mediated VLP infectivity resembles MHV-A59 infectivity. The system can be used to identify domains in S that are essential for infectivity. As a first application, we investigated the requirements of cleavage of S for the infectivity of MHV-A59. We inserted three mutant S proteins that were previously shown to be uncleaved (E. C. W. Bos, L. Heijnen, W. Luytjes, and W. J. M. Spaan, Virology 214:453-463, 1995) into the VLPs. Here we show that cleavage of the spike protein of MHV-A59 is not required for infectivity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371603      PMCID: PMC230247     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 2.  Hybridization of nucleic acids immobilized on solid supports.

Authors:  J Meinkoth; G Wahl
Journal:  Anal Biochem       Date:  1984-05-01       Impact factor: 3.365

3.  Nucleotide sequence of cdna coding for Semliki Forest virus membrane glycoproteins.

Authors:  H Garoff; A M Frischauf; K Simons; H Lehrach; H Delius
Journal:  Nature       Date:  1980-11-20       Impact factor: 49.962

4.  Assembled coronavirus from complementation of two defective interfering RNAs.

Authors:  K H Kim; K Narayanan; S Makino
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

5.  Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin.

Authors:  P J Rottier; M C Horzinek; B A van der Zeijst
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

6.  Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell--cell fusion.

Authors:  A R Collins; R L Knobler; H Powell; M J Buchmeier
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

7.  Coronavirus glycoprotein E1, a new type of viral glycoprotein.

Authors:  H Niemann; H D Klenk
Journal:  J Mol Biol       Date:  1981-12-25       Impact factor: 5.469

8.  Isolation and identification of virus-specific mRNAs in cells infected with mouse hepatitis virus (MHV-A59).

Authors:  W J Spaan; P J Rottier; M C Horzinek; B A van der Zeijst
Journal:  Virology       Date:  1981-01-30       Impact factor: 3.616

9.  Acylation of viral spike glycoproteins: a feature of enveloped RNA viruses.

Authors:  M F Schmidt
Journal:  Virology       Date:  1982-01-15       Impact factor: 3.616

10.  Tunicamycin resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein.

Authors:  K V Holmes; E W Doller; L S Sturman
Journal:  Virology       Date:  1981-12       Impact factor: 3.616

View more
  26 in total

1.  Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8.

Authors:  Bruce D Zelus; Jeanne H Schickli; Dianna M Blau; Susan R Weiss; Kathryn V Holmes
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  The coronavirus spike protein induces endoplasmic reticulum stress and upregulation of intracellular chemokine mRNA concentrations.

Authors:  Gijs A Versteeg; Paula S van de Nes; Peter J Bredenbeek; Willy J M Spaan
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

3.  The glycoprotein cytoplasmic tail of Uukuniemi virus (Bunyaviridae) interacts with ribonucleoproteins and is critical for genome packaging.

Authors:  Anna K Overby; Ralf F Pettersson; Etienne P A Neve
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

4.  Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy.

Authors:  Benjamin W Neuman; Brian D Adair; Craig Yoshioka; Joel D Quispe; Gretchen Orca; Peter Kuhn; Ronald A Milligan; Mark Yeager; Michael J Buchmeier
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function.

Authors:  R J Wool-Lewis; P Bates
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

6.  Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies.

Authors:  H Ito; S Watanabe; A Takada; Y Kawaoka
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry.

Authors:  Zhaozhu Qiu; Susan T Hingley; Graham Simmons; Christopher Yu; Jayasri Das Sarma; Paul Bates; Susan R Weiss
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

8.  Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier.

Authors:  L Kuo; G J Godeke; M J Raamsman; P S Masters; P J Rottier
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

9.  Identification and characterization of a proteolytically primed form of the murine coronavirus spike proteins after fusion with the target cell.

Authors:  Oliver Wicht; Christine Burkard; Cornelis A M de Haan; Frank J M van Kuppeveld; Peter J M Rottier; Berend Jan Bosch
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

10.  A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge.

Authors:  Robert B Mandell; Ramesh Koukuntla; Laura J K Mogler; Andrea K Carzoli; Alexander N Freiberg; Michael R Holbrook; Brian K Martin; William R Staplin; Nicholas N Vahanian; Charles J Link; Ramon Flick
Journal:  Virology       Date:  2009-11-24       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.